|
KR100217772B1
(ko)
*
|
1996-09-03 |
1999-09-01 |
최진호 |
조명기기의 램프 과열방지 장치 및 방법
|
|
US20020092987A1
(en)
*
|
1998-09-05 |
2002-07-18 |
Taehee Cho |
Photo detect device using quantum dots and materialization method thereof
|
|
US6936258B1
(en)
*
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
PL229487B1
(pl)
|
2002-11-12 |
2018-07-31 |
Brigham & Womens Hospital Inc |
Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego
|
|
AU2003298770A1
(en)
*
|
2002-12-02 |
2004-06-23 |
Biosynexus Inc |
Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
|
|
CA2517439C
(en)
|
2003-03-07 |
2013-07-23 |
Wyeth Holdings Corporation |
Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
|
|
NZ553776A
(en)
*
|
2004-09-22 |
2010-05-28 |
Glaxosmithkline Biolog Sa |
Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide.
|
|
AU2011265368B9
(en)
*
|
2004-09-22 |
2012-11-29 |
Biosynexus Incorporated |
Immunogenic composition
|
|
US20060134141A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
|
WO2006076058A1
(en)
*
|
2005-01-10 |
2006-07-20 |
Nabi Biopharmaceuticals |
Method of treating staphylococcus aureus infection
|
|
US20060228368A1
(en)
*
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
|
FR2884830A1
(fr)
|
2005-04-25 |
2006-10-27 |
Sanofi Pasteur Sa |
Procede de production de souches de staphylococcus aureus surproductrices
|
|
ES2372537T3
(es)
*
|
2005-07-29 |
2012-01-23 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services |
Exotoxinas de pseudomonas mutadas con antigenicidad reducida.
|
|
EP2476433A1
(en)
*
|
2006-03-30 |
2012-07-18 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
FR2899110A1
(fr)
*
|
2006-03-31 |
2007-10-05 |
Sanofi Pasteur Sa |
Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus
|
|
GB0700136D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
US9181329B2
(en)
|
2007-08-31 |
2015-11-10 |
The University Of Chicago |
Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
|
|
JP5658564B2
(ja)
*
|
2007-08-31 |
2015-01-28 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
|
|
CN102159540B
(zh)
|
2008-07-21 |
2015-08-12 |
布赖汉姆妇女医院 |
与合成的β-1,6葡糖胺寡糖相关的方法和组合物
|
|
WO2010014304A1
(en)
*
|
2008-07-29 |
2010-02-04 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
HUE026855T2
(en)
|
2009-04-03 |
2016-07-28 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
SA110310528B1
(ar)
|
2009-06-22 |
2014-07-02 |
Wyeth Llc |
التركيبات المولدة للمناعة لأنتيجينات ستافيلوكوكس أوريس
|
|
SG10201406432RA
(en)
|
2009-06-22 |
2014-11-27 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
BR112012009014B8
(pt)
|
2009-09-30 |
2022-10-04 |
Novartis Ag |
Processo para preparar conjugado de polissacarídeo capsular de s. aureus tipo 5 ou tipo 8 e molécula de transporte crm197, conjugado e composição imunogênica
|
|
HUE034251T2
(en)
|
2009-10-30 |
2018-02-28 |
Glaxosmithkline Biologicals Sa |
Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
|
|
EP2525800B1
(en)
*
|
2010-01-19 |
2018-07-04 |
Universitätsklinikum Freiburg |
Enterococcal cell wall components and antibacterial use thereof
|
|
CA2803298C
(en)
|
2010-07-02 |
2020-07-14 |
The University Of Chicago |
Compositions and methods related to protein a (spa) variants
|
|
CN102539704A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102565336A
(zh)
*
|
2010-12-13 |
2012-07-11 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102565354A
(zh)
*
|
2010-12-13 |
2012-07-11 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102539708A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102565332A
(zh)
*
|
2010-12-13 |
2012-07-11 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102539726A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102539702A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
US9777076B2
(en)
|
2012-07-16 |
2017-10-03 |
Pfizer Inc. |
Saccharides and uses thereof
|
|
GB201310008D0
(en)
|
2013-06-05 |
2013-07-17 |
Glaxosmithkline Biolog Sa |
Immunogenic composition for use in therapy
|
|
AU2015359503B2
(en)
|
2014-12-10 |
2019-05-09 |
Glaxosmithkline Biologicals Sa |
Method of treatment
|
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
|
US12397014B2
(en)
|
2019-02-05 |
2025-08-26 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide compositions for use in treating filariasis
|
|
US12514914B2
(en)
|
2019-05-14 |
2026-01-06 |
The University Of Chicago |
Methods and compositions comprising Staphylococcus protein a (SpA) variants
|
|
EP3777884A1
(en)
|
2019-08-15 |
2021-02-17 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
CA3152520A1
(en)
*
|
2019-08-27 |
2021-03-04 |
OneBioPharma, Inc. |
Antimicrobial vaccine compositions
|
|
CN114929750B
(zh)
|
2019-09-13 |
2024-11-22 |
芝加哥大学 |
用于治疗葡萄球菌感染的方法和组合物
|
|
US20260007731A1
(en)
*
|
2022-01-05 |
2026-01-08 |
Bluewillow Biologics, Inc. |
Intranasal polysaccharide conjugate nanomulsion vaccines and methods of using the same
|